QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2022 作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi 收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23 Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)  apatinib  case report   Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文 BMC Medicine, 2022, 卷号: 20, 期号: 1 作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun 收藏  |  浏览/下载：123/0  |  提交时间：2022/11/21 Tucidinostat  Tumor microenvironment  PD-L1  CCL5  Solid tumor   Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches 期刊论文 PHARMACEUTICS, 2022, 卷号: 14 作者:  Ji, Qing;  Wu, Yuchen;  Albers, Andreas;  Fang, Meiyu;  Qian, Xu 收藏  |  浏览/下载：16/0  |  提交时间：2022/12/22 oncolytic viruses  nanotechnology  oncolytic virotherapy  immunotherapy  melanoma  head and neck cancer   Engineering CpG-ASO-Pt-Loaded Macrophages (CAP@M) For Synergistic Chemo-/Gene-/Immuno-Therapy 期刊论文 ADVANCED HEALTHCARE MATERIALS, 2022 作者:  Wang, Yuqi;  Zhang, Lingpu;  Liu, Yan;  Tang, Linlin;  He, Juan 收藏  |  浏览/下载：18/0  |  提交时间：2022/12/23 cell therapy  DNA nanobiotechnology  drug delivery  macrophages  synergistic therapy   Preparation of Doxorubicin-Loaded Carboxymethyl-beta-Cyclodextrin/Chitosan Nanoparticles with Antioxidant, Antitumor Activities and pH-Sensitive Release 期刊论文 MARINE DRUGS, 2022, 卷号: 20, 期号: 5, 页码: 18 作者:  Mi, Yingqi;  Zhang, Jingjing;  Tan, Wenqiang;  Miao, Qin;  Li, Qing 收藏  |  浏览/下载：38/0  |  提交时间：2022/07/26 chitosan nanoparticles  cyclodextrin  antioxidant activity  antitumor activity  drug release   Tisotumab vedotin for the treatment of cervical carcinoma 期刊论文 DRUGS OF TODAY, 2022, 卷号: 58, 期号: 5, 页码: 213-222 作者:  Song, Xin;  Li, Ruyi;  Wang, Hongwei;  Song, Peng;  Guo, Wenjing 收藏  |  浏览/下载：22/0  |  提交时间：2022/06/21 Tisotumab vedotin  Antibody-drug conjugates  Cervical cancer  Tissue factor  Monomethyl auristatin E  Targeted antitumor drugs  Cancer immunotherapy  Gynecological cancers